Search Results 31-40 of 17011 for hla genotype

  1. Publications - Francisco Alvarez, M.D. - Mayo Clinic

    Clinical utility of 1:16 serum dilution as a predictor of response to therapeutic plasma exchange for HLA antibody-mediated rejection treatment and overall ...

  2. A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in People With Celiac Disease - Mayo Clinic

    - HLA-DQ8 genotype. - Previous oral gluten challenge within 12 months. - Selective IgA deficiency. - Diagnosis of Type-1 diabetes. - Active gastrointestinal ...

  3. A Study to Assess the Safety and Tolerability of Single and Multiple Doses of KAN-101 in Celiac Disease Patients - Mayo Clinic

    Has HLA-DQ2.5 genotype (HLA-DQA1*05 and HLA-DQB1*02) (homozygotes or heterozygotes). Has followed a GFD for > 12 months immediately prior to study entry ...

  4. Stevens-Johnson syndrome - Symptoms & causes - Mayo Clinic

    HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: A systematic review. Clinical Pharmacology and Therapeutics. 2012;92:757. Wetter DA ...

  5. Mayo GBM PDX Line Data - Translational Neuro-Oncology: Jann N. Sarkaria - Mayo Clinic Research

    Genotype: common genomic alterations commonly found in glioblastoma, including MGMT methylation and IDH status; Copy number variation (CNV); Invasiveness ...

  6. Stevens-Johnson syndrome - Diagnosis & treatment - Mayo Clinic

    HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: A systematic review. Clinical Pharmacology and Therapeutics. 2012;92:757. Wetter DA ...

  7. Cardiovascular Medicine - Clinical trials

    To evaluate the incidence of occult heritable cardiovascular disease in various populations. To correlate imaging and pathological phenotype with genotype to ...

  8. A Study of the Safety, Effectiveness and Tolerability of Nexvax-2 in Patients with Celiac Disease (CeD) - Mayo Clinic

    The purpose of this study is to evaluate the human leukocyte antigen (HLA)-DQ 2.5+ in adults with celiac disease (CeD). Participation eligibility.

  9. A Study to Analyze Phenotype-Genotype Vascular Anomalies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Treating Highly Sensitized Patients on the Kidney Transplant Waiting List by Depleting Their B-cells Using Chimeric Antigen Receptor T Cells (CAR-T) - Mayo Clinic

    The purpose of this study is to decrease the waiting time on the transplant list for patients who have high level of anti-HLA antibodies with ESRD and improve ...